RWM
ROIV icon

Raffa Wealth Management’s Roivant Sciences ROIV Stock Holding History

Raffa Wealth Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.76K Buy
191
+24
+14% +$709 ﹤0.01% 518
2026
Q1 		$4.63K Buy
167
+7
+4% +$180 ﹤0.01% 552
2025
Q4 		$3.47K Hold
160
– – ﹤0.01% 593
2025
Q3 		$2.42K Hold
160
– – ﹤0.01% 661
2025
Q2 		$1.8K Hold
160
– – ﹤0.01% 718
2025
Q1 		$1.61K Hold
160
– – ﹤0.01% 693
2024
Q4 		$1.89K Hold
160
– – ﹤0.01% 682
2024
Q3 		$1.85K Hold
160
– – ﹤0.01% 658
2024
Q2 		$1.69K Hold
160
– – ﹤0.01% 759
2024
Q1 		$1.69K Hold
160
– – ﹤0.01% 750
2023
Q4 		$1.8K Hold
160
– – ﹤0.01% 651
2023
Q3 		$1.87K Buy
+160
New +$1.81K ﹤0.01% 606

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raffa Wealth Management's ROIV Position: Q2 2026 in Review

Raffa Wealth Management increased its Roivant Sciences (ROIV) stake by 14% in Q2 2026, buying an estimated $709 and bringing the position to 191 shares worth $6.76K. The position accounts for ﹤0.01% of the portfolio, ranked #518.

Raffa Wealth Management first reported a position in ROIV in Q3 2023 and has held it in 12 quarters since. 464 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Raffa Wealth Management held 191 shares of Roivant Sciences worth $6.76K as of Q2 2026.
  • Raffa Wealth Management bought 24 Roivant Sciences shares in Q2 2026, an estimated $709.
  • Roivant Sciences made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #518 holding.
  • Raffa Wealth Management first reported a position in Roivant Sciences in Q3 2023 and has held it in 12 quarters since.
  • 464 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.